CDKN2A and clear cell renal carcinoma: El-mokadem et al. [31] found that when patients with renal clear cell carcinoma developed p16 gene mutation, the degree of malignancy was usually high, and p16 gene mutation increased the risk of tumor metastasis, leading to higher tumor recurrence and metastasis, which was associated with poor prognosis.